MARLBOROUGH, Mass., Dec. 28, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in the 41st Annual J.P. Morgan Healthcare Conference. Brian McKelligon, CEO, is scheduled to present on Wednesday, January 11th, 2023 at 9:45 a.m. PT. A live and archived webcast of the event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/. About Akoya BiosciencesAs The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com. Investor Contact:Priyam ShahSr. Director, Investor RelationsAkoya Biosciences, Inc.investors@akoyabio.com Media Contact:Christine Quern(617) 650-8497media@akoyabio.com